Opiant Pharmaceuticals Inc
(OPNT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 07-2013 | 12-2012 | 12-2006 | |
| Operating Expenses | 8,807 | 8,524 | 0 |
| Operating Income | -8,807 | -8,524 | N/A |
| Interest Expense | 553 | 553 | 0 |
| Other Income | 182 | -101 | 0 |
| Pre-tax Income | -9,178 | -9,178 | 0 |
| Net Income Continuous | -9,178 | -9,178 | N/A |
| Net Income | $-9,178 | $-9,178 | $N/A |
| EPS Basic Total Ops | -0.06 | N/A | N/A |
| EPS Basic Continuous Ops | -0.06 | N/A | N/A |
| EPS Diluted Total Ops | -0.06 | N/A | N/A |
| EPS Diluted Continuous Ops | -0.06 | N/A | N/A |
| EBITDA(a) | $-8,382 | $-8,524 | $N/A |